Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Efficacy and Safety of Xuefu Zhuyu Capsule in Treating "Qizhi Xueyu Zheng" (Qi Stagnation and Blood Stasis Syndrome): a Randomized, Double-blind, Placebo-controlled, Adaptive Enrichment, Multicenter Controlled Trial

NCT04218487 is registered in ClinicalTrials.gov with Zhong Wang as lead sponsor.

NCT NCT04218487
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04218487 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Efficacy and Safety of Xuefu Zhuyu Capsule in Treating "Qizhi Xueyu Zheng" (Qi Stagnation and Blood Stasis Syndrome): a Randomized, Double-blind, Placebo-controlled, Adaptive Enrichment, Multicenter Controlled Trial
Lead sponsor
Zhong Wang
Phase
Phase 4
Overall status
Unknown status
Start date
December 31, 2019
Completion date
June 30, 2024
Enrollment
720 (estimated)
Sites
12

Conditions

As the registry lists them; a condition with its own page is linked.

chinese medicine, chronic insomnia, endometriosis, headache, stable coronary heart disease